TherapeuticsMD, Inc. (TXMD:NASDAQ) closed at $1.90 on October 21, 2026, up 1.06% on the day. The stock trades 35.6% below its 52-week high of $2.95 and 71.2% above its 52-week low of $1.11. Over the past year, it gained 55.7%. TherapeuticsMD, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 21, 2025, TXMD closed higher on 111 days (44%). Its best day was November 11, 2025 (+21.48%) and its worst was November 17, 2025 (-22.45%). The stock moved 10% or more in a single session 14 times. It opened at least 5% above the previous day's high 1 time.
TherapeuticsMD, Inc. operates as a women's health care product company. The company manufactures and distributes prescription and over-the-counter product lines, including prenatal vitamins, iron supplements, and natural menopause relief products under the vitaMedMD brand, as well as generic formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. Its pipeline of hormone therapy drug candidates include TX-001HR, a combination of estradiol and progesterone drug candidate under clinical trials for the treatment of moderate to severe vasomotor symptoms due to menopause; TX-002HR, a natural progesterone formulation for the treatment of secondary amenorrhea without the potentially allergenic component of peanut oil; and TX-004HR, an applicator-free vaginal estradiol softgel drug candidate for the treatment of vulvar and vaginal atrophy in post-menopausal women with vaginal linings that do not receive enough estrogen. The company markets its products primarily through a direct national sales force to health care providers in the OB/GYN market space. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Find more stocks like TXMD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.